We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
OGT Featured in the Sunday Times Biotech Supplement
News

OGT Featured in the Sunday Times Biotech Supplement

OGT Featured in the Sunday Times Biotech Supplement
News

OGT Featured in the Sunday Times Biotech Supplement

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "OGT Featured in the Sunday Times Biotech Supplement"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, was featured in this week’s edition of the UK weekly broadsheet, The Sunday Times (16th of January, 2011).

As part of a pullout focusing on recent developments in life sciences and biotechnology, the article, entitled ‘Better diagnosis, less cost’, describes how OGT’s recent innovations in the fields of biomarker discovery and chromosome analysis will help push healthcare costs down, while improving the accuracy of early disease diagnosis.

In a proof-of-principle case study, protein markers that correctly indicated the presence of prostate cancer with over 90% accuracy were identified using OGT’s biomarker discovery technology. As well as protein based screens, OGT employs its expertise in the design of DNA microarrays to improve genetic tests for developmental delay and other unexplained genetic abnormalities.

This is achieved using OGT’s CytoSure™ arrays and software, which deliver a five-fold improvement in accuracy over traditional karyotyping techniques when used to detect genetic aberrations.

Advertisement